Helen Torley, who was highlighted in 2016 as the only female CEO of a public life sciences company in San Diego, was recognized last week for her operational excellence at Halozyme Therapeutics (NASDAQ: HALO).
Torley, who joined San Diego-based Halozyme as CEO in 2014, was among five local business leaders to win the 2018 San Diego Entrepreneur of the Year award. The award ceremony, held Thursday night at the Fairmont Grand Del Mar Hotel, culminated a selection process that began early this year. (The 16 finalists are in the above photo.)
The regional competition is part of the global Entrepreneur of the Year program overseen by EY, the business advisory and accounting services firm. EY says the program is intended to highlight business leaders who are excelling in areas such as innovation, financial performance, and personal commitment to their businesses and communities.
The EY dinner gala, which included a performance by dancers wearing LED-enhanced overalls and motorcycle helmets (think Daft Punk, sort of) also gave EvoNexus CEO Rory Moore an award for his outstanding contributions and support for entrepreneurship in San Diego.
The regional award winners are now eligible for consideration for the Entrepreneur of the Year National Program. The overall national award winner will be announced in Palm Springs, CA, on November 10 as part of EY’s annual Strategic Growth Forum. EY says its Entrepreneur of the Year program, now in its 32nd year, has expanded to recognize business leaders in more than 60 countries throughout the world.
Of the five winners in this year’s event, four were the CEOs of companies focused in the life sciences sector. Edico Genome, acquired last month for $100 million by Illumina (NASDAQ: ILMN) developed specialized hardware and software to accelerate the readout of next generation DNA sequencing. Novacyte is a contract research organization for medical device makers and drug developers.
This year’s Entrepreneur of the Year award winners in San Diego are:
—Life Sciences: Kevin Gorman, CEO, Neurocrine Biosciences
—Technology: Pieter van Rooyen, Founding CEO, Edico Genome
—Operational Excellence: Helen Torley, CEO, Halozyme Therapeutics
—Services: Tim Gleeson, chairman and CEO, Novasyte
—Real Estate and Hospitality: Mark Gleiberman, Founding CEO, MG Properties Group